Inhibitory Effects of Bovine Lactoferricin-Lactoferrampin on Senecavirus A and Foot-and-Mouth Disease Virus with Recombinant Lactobacillus Oral Treatment in Mice

Foot-and-mouth disease virus (FMDV) and Senecavirus A (SVA) have similar pathogenic characteristics, and both are important pathogens that harm the livestock industry. Studies have shown that lactoferrin peptides can inhibit the replication of various viruses and enhance the body’s immune functions....

Full description

Saved in:
Bibliographic Details
Main Authors: Wenyue Zhao, Senhao Zhang, Ling Sui, Xiaona Wang, Jiaxuan Li, Wen Cui, Yanping Jiang, Xinyuan Qiao, Lijie Tang
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Veterinary Sciences
Subjects:
Online Access:https://www.mdpi.com/2306-7381/12/3/199
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849339908374659072
author Wenyue Zhao
Senhao Zhang
Ling Sui
Xiaona Wang
Jiaxuan Li
Wen Cui
Yanping Jiang
Xinyuan Qiao
Lijie Tang
author_facet Wenyue Zhao
Senhao Zhang
Ling Sui
Xiaona Wang
Jiaxuan Li
Wen Cui
Yanping Jiang
Xinyuan Qiao
Lijie Tang
author_sort Wenyue Zhao
collection DOAJ
description Foot-and-mouth disease virus (FMDV) and Senecavirus A (SVA) have similar pathogenic characteristics, and both are important pathogens that harm the livestock industry. Studies have shown that lactoferrin peptides can inhibit the replication of various viruses and enhance the body’s immune functions. Based on this, in the present study, we aimed to investigate the effects of bovine lactoferricin-lactoferrampin (LFCA) on replicating FMDV and SVA and to analyze its role in the cellular antioxidant response caused by viral infection; in addition, we fed mice with constructed recombinant <i>Lactobacillus reuteri</i> expressing LFCA. Treatment with LFCA at different stages significantly inhibited the replication of both SVA and FMDV. Pretreatment before SVA infection achieved an inhibition rate of up to 94.9%, while treatment during the FMDV replication stage achieved an inhibition rate of 74.3%. After infection with either virus, intracellular ROS and MDA levels were significantly reduced, as was GSH-Px activity. However, SOD activity showed no significant difference, compared with the virus-exposed group, and remained at a high level, suggesting an increased cellular antioxidant capacity. LFCA treatment significantly increased the transcription levels of the <i>Nrf2</i>, <i>Ho-1</i>, and <i>Nqo1</i> genes. In mouse experiments, the LFCA-treated group showed significantly lower viral loads in lung and intestinal tissues, compared with the SVA infection group, validating LFCA’s protective effect against SVA infection. These findings demonstrate the potential of LFCA as an antiviral drug.
format Article
id doaj-art-3a84b1e2f4d9411d91b4aeb7b04b0933
institution Kabale University
issn 2306-7381
language English
publishDate 2025-02-01
publisher MDPI AG
record_format Article
series Veterinary Sciences
spelling doaj-art-3a84b1e2f4d9411d91b4aeb7b04b09332025-08-20T03:44:01ZengMDPI AGVeterinary Sciences2306-73812025-02-0112319910.3390/vetsci12030199Inhibitory Effects of Bovine Lactoferricin-Lactoferrampin on Senecavirus A and Foot-and-Mouth Disease Virus with Recombinant Lactobacillus Oral Treatment in MiceWenyue Zhao0Senhao Zhang1Ling Sui2Xiaona Wang3Jiaxuan Li4Wen Cui5Yanping Jiang6Xinyuan Qiao7Lijie Tang8College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, ChinaCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, ChinaCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, ChinaCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, ChinaCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, ChinaCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, ChinaCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, ChinaCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, ChinaCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, ChinaFoot-and-mouth disease virus (FMDV) and Senecavirus A (SVA) have similar pathogenic characteristics, and both are important pathogens that harm the livestock industry. Studies have shown that lactoferrin peptides can inhibit the replication of various viruses and enhance the body’s immune functions. Based on this, in the present study, we aimed to investigate the effects of bovine lactoferricin-lactoferrampin (LFCA) on replicating FMDV and SVA and to analyze its role in the cellular antioxidant response caused by viral infection; in addition, we fed mice with constructed recombinant <i>Lactobacillus reuteri</i> expressing LFCA. Treatment with LFCA at different stages significantly inhibited the replication of both SVA and FMDV. Pretreatment before SVA infection achieved an inhibition rate of up to 94.9%, while treatment during the FMDV replication stage achieved an inhibition rate of 74.3%. After infection with either virus, intracellular ROS and MDA levels were significantly reduced, as was GSH-Px activity. However, SOD activity showed no significant difference, compared with the virus-exposed group, and remained at a high level, suggesting an increased cellular antioxidant capacity. LFCA treatment significantly increased the transcription levels of the <i>Nrf2</i>, <i>Ho-1</i>, and <i>Nqo1</i> genes. In mouse experiments, the LFCA-treated group showed significantly lower viral loads in lung and intestinal tissues, compared with the SVA infection group, validating LFCA’s protective effect against SVA infection. These findings demonstrate the potential of LFCA as an antiviral drug.https://www.mdpi.com/2306-7381/12/3/199foot-and-mouth disease virusSenecavirus Abovine lactoferricin-lactoferrampinantioxidantrecombinant <i>Lactobacillus reuteri</i>
spellingShingle Wenyue Zhao
Senhao Zhang
Ling Sui
Xiaona Wang
Jiaxuan Li
Wen Cui
Yanping Jiang
Xinyuan Qiao
Lijie Tang
Inhibitory Effects of Bovine Lactoferricin-Lactoferrampin on Senecavirus A and Foot-and-Mouth Disease Virus with Recombinant Lactobacillus Oral Treatment in Mice
Veterinary Sciences
foot-and-mouth disease virus
Senecavirus A
bovine lactoferricin-lactoferrampin
antioxidant
recombinant <i>Lactobacillus reuteri</i>
title Inhibitory Effects of Bovine Lactoferricin-Lactoferrampin on Senecavirus A and Foot-and-Mouth Disease Virus with Recombinant Lactobacillus Oral Treatment in Mice
title_full Inhibitory Effects of Bovine Lactoferricin-Lactoferrampin on Senecavirus A and Foot-and-Mouth Disease Virus with Recombinant Lactobacillus Oral Treatment in Mice
title_fullStr Inhibitory Effects of Bovine Lactoferricin-Lactoferrampin on Senecavirus A and Foot-and-Mouth Disease Virus with Recombinant Lactobacillus Oral Treatment in Mice
title_full_unstemmed Inhibitory Effects of Bovine Lactoferricin-Lactoferrampin on Senecavirus A and Foot-and-Mouth Disease Virus with Recombinant Lactobacillus Oral Treatment in Mice
title_short Inhibitory Effects of Bovine Lactoferricin-Lactoferrampin on Senecavirus A and Foot-and-Mouth Disease Virus with Recombinant Lactobacillus Oral Treatment in Mice
title_sort inhibitory effects of bovine lactoferricin lactoferrampin on senecavirus a and foot and mouth disease virus with recombinant lactobacillus oral treatment in mice
topic foot-and-mouth disease virus
Senecavirus A
bovine lactoferricin-lactoferrampin
antioxidant
recombinant <i>Lactobacillus reuteri</i>
url https://www.mdpi.com/2306-7381/12/3/199
work_keys_str_mv AT wenyuezhao inhibitoryeffectsofbovinelactoferricinlactoferrampinonsenecavirusaandfootandmouthdiseaseviruswithrecombinantlactobacillusoraltreatmentinmice
AT senhaozhang inhibitoryeffectsofbovinelactoferricinlactoferrampinonsenecavirusaandfootandmouthdiseaseviruswithrecombinantlactobacillusoraltreatmentinmice
AT lingsui inhibitoryeffectsofbovinelactoferricinlactoferrampinonsenecavirusaandfootandmouthdiseaseviruswithrecombinantlactobacillusoraltreatmentinmice
AT xiaonawang inhibitoryeffectsofbovinelactoferricinlactoferrampinonsenecavirusaandfootandmouthdiseaseviruswithrecombinantlactobacillusoraltreatmentinmice
AT jiaxuanli inhibitoryeffectsofbovinelactoferricinlactoferrampinonsenecavirusaandfootandmouthdiseaseviruswithrecombinantlactobacillusoraltreatmentinmice
AT wencui inhibitoryeffectsofbovinelactoferricinlactoferrampinonsenecavirusaandfootandmouthdiseaseviruswithrecombinantlactobacillusoraltreatmentinmice
AT yanpingjiang inhibitoryeffectsofbovinelactoferricinlactoferrampinonsenecavirusaandfootandmouthdiseaseviruswithrecombinantlactobacillusoraltreatmentinmice
AT xinyuanqiao inhibitoryeffectsofbovinelactoferricinlactoferrampinonsenecavirusaandfootandmouthdiseaseviruswithrecombinantlactobacillusoraltreatmentinmice
AT lijietang inhibitoryeffectsofbovinelactoferricinlactoferrampinonsenecavirusaandfootandmouthdiseaseviruswithrecombinantlactobacillusoraltreatmentinmice